Position in ARCT
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$87,540
+$69,576 QoQ
Shares Held
13,027
+459.8% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#85
of 133 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARCT Over Time
Shares Held
Position Value (USD)
Derivatives in ARCT
reported options exposure · as of Dec 31, 2024CallValue
$407,280
CallShares
24,000
PutValue
$407,280
PutShares
24,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITIGROUP INC holds $2,077,377,990 across 384 Biotechnology names. ARCT ranks #267 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
706,968 | $351,172,214 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
346,637 | $216,142,034 | |
| 3 | MRNA |
Moderna, Inc.
|
2,165,414 | $151,643,941 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
2,225,190 | $78,749,472 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
227,786 | $68,570,419 | |
| 6 | INCY |
Incyte Corp
|
586,431 | $66,477,817 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
864,101 | $64,358,241 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
247,052 | $46,267,897 |
All Filings in ARCT
Export CSV
33 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $87,540 | 13,027 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $17,964 | 2,327 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $35,130 | 5,731 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $50,515 | 2,741 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $215,808 | 16,588 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $593,483 | 56,042 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $993,236 | 58,529 | Shares | Defined | 2025-02-12 | |
| 2024-12-31 | $407,280 | 24,000 | Call | Defined | 2025-02-12 | |
| 2024-12-31 | $407,280 | 24,000 | Put | Defined | 2025-02-12 | |
| 2024-09-30 | $455,263 | 19,615 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $363,666 | 14,935 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $4,606,463 | 136,407 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $1,540,933 | 48,872 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,464,653 | 57,325 | Shares | Defined | 2023-12-06 | |
| 2023-09-30 | $740,950 | 29,000 | Put | Defined | 2023-12-06 | |
| 2023-09-30 | $740,950 | 29,000 | Call | Defined | 2023-12-06 | |
| 2023-06-30 | $1,535,669 | 53,545 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $3,166,221 | 132,091 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $593,600 | 35,000 | Put | Defined | 2023-02-09 | |
| 2022-12-31 | $1,570,733 | 92,614 | Shares | Defined | 2023-02-09 | |
| 2022-12-31 | $593,600 | 35,000 | Call | Defined | 2023-02-09 | |
| 2022-09-30 | $2,565,727 | 173,126 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $1,996,996 | 126,874 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $1,248,652 | 46,315 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $4,804,786 | 129,824 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $3,088,308 | 64,636 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $4,856,276 | 143,507 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $3,461,807 | 83,821 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $1,429,761 | 32,959 | Shares | Defined | 2021-02-11 | |
| 2020-12-31 | $1,088,838 | 25,100 | Put | Defined | 2021-02-11 | |
| 2020-09-30 | $99,442 | 2,318 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $223,323 | 4,778 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $21,947 | 1,615 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||